饮食干预治疗银屑病的相关进展

doi:10.35541/cjd.20200892

中华皮肤科杂志 ›› 2023, Vol. 56 ›› Issue (4): 357-360.doi: 10.35541/cjd.20200892

饮食干预治疗银屑病的相关进展

金利平朱武鲁艳刘盼盼谭敏佳王英杨晶徐黎聪胡琨匡叶红

中南大学湘雅医院皮肤科，长沙 410008

收稿日期:2020-09-08 修回日期:2021-07-12 发布日期:2023-03-31
通讯作者: 匡叶红 E-mail:yh_927@126.com
基金资助:
国家自然科学基金（81974479、81773329）

Dietary intervention for the treatment of psoriasis

Jin Liping, Zhu Wu, Lu Yan, Liu Panpan, Tan Minjia, Wang Ying, Yang Jing, Xu Licong, Hu Kun, Kuang Yehong

Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China

Received:2020-09-08 Revised:2021-07-12 Published:2023-03-31
Contact: Kuang Yehong E-mail:yh_927@126.com
Supported by:
National Natural Science Foundation of China （81974479, 81773329）

摘要/Abstract

摘要： 【摘要】本文综述银屑病患者的饮食特点，探讨无麸质饮食、地中海饮食、饮食干预导致的体重减轻对银屑病的影响，分析补充鱼油、维生素D、维生素B12、硒、益生菌等膳食补充剂治疗银屑病的疗效。

关键词: 银屑病, 膳食疗法, 膳食补充剂, 饮食模式

Abstract: 【Abstract】 This review summarizes dietary characteristics of patients with psoriasis, discusses effects of gluten-free diet, Mediterranean diet and dietary intervention-induced weight loss on psoriasis, and analyzes the efficacy of dietary supplements in the treatment of psoriasis, such as fish oil, vitamin D, vitamin B12, selenium, and probiotics.

Key words: Psoriasis, Diet therapy, Dietary supplements, Dietary pattern

金利平朱武鲁艳刘盼盼谭敏佳王英杨晶徐黎聪胡琨匡叶红. 饮食干预治疗银屑病的相关进展[J]. 中华皮肤科杂志, 2023,56(4):357-360. doi:10.35541/cjd.20200892

Jin Liping, Zhu Wu, Lu Yan, Liu Panpan, Tan Minjia, Wang Ying, Yang Jing, Xu Licong, Hu Kun, Kuang Yehong. Dietary intervention for the treatment of psoriasis[J]. Chinese Journal of Dermatology, 2023, 56(4): 357-360.doi:10.35541/cjd.20200892

参考文献 45

［1］	Murphy EC, Nussbaum D, Prussick R, et al. Use of complementary and alternative medicine by patients with psoriasis［J］. J Am Acad Dermatol, 2019,81（1）:280⁃283. doi: 10.1016/j.jaad.2019.03.059.
［2］	Yamashita H, Morita T, Ito M, et al. Dietary habits in Japanese patients with psoriasis and psoriatic arthritis: low intake of meat in psoriasis and high intake of vitamin A in psoriatic arthritis［J］. J Dermatol, 2019,46（9）:759⁃769. doi: 10.1111/1346⁃8138. 15032.
［3］	Rocha A, Bortoletto MC, da Costa AC, et al. Low serum lycopene, and adequate α⁃tocopherol levels in patients with psoriasis: a cross⁃sectional study［J/OL］. Nutr Health, 2021:2601060211014127［2021⁃07⁃12］. doi: 10.1177/02601060211014127. https://journals. sagepub.com/doi/10.1177/02601060211014127?url_ver=Z39.88⁃2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed.
［4］	Shi Z, Wu X, Yu S, et al. Short⁃term exposure to a Western diet induces psoriasiform dermatitis by promoting accumulation of IL⁃17A⁃producing γδ T cells［J］. J Invest Dermatol, 2020,140（9）:1815⁃1823. doi: 10.1016/j.jid.2020.01.020.
［5］	Shi Z, Wu X, Santos Rocha C, et al. Short⁃term Western diet intake promotes IL⁃23⁃mediated skin and joint inflammation accompanied by changes to the gut microbiota in mice［J］. J Invest Dermatol, 2021,141（7）:1780⁃1791. doi: 10.1016/j.jid. 2020.11.032.
［6］	Polo T, Corrente JE, Miot L, et al. Dietary patterns of patients with psoriasis at a public healthcare institution in Brazil［J］. An Bras Dermatol, 2020,95（4）:452⁃458. doi: 10.1016/j.abd.2020. 02.002.
［7］	Bridgman AC, Qureshi AA, Li T, et al. Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: a cohort study［J］. J Am Acad Dermatol, 2019,80（6）:1682⁃1690. doi: 10.1016/j.jaad.2019.02.038.
［8］	Acharya P, Mathur M. Association between psoriasis and celiac disease: a systematic review and meta⁃analysis［J］. J Am Acad Dermatol, 2020,82（6）:1376⁃1385. doi: 10.1016/j.jaad.2019.11. 039.
［9］	Drucker AM, Qureshi AA, Thompson JM, et al. Gluten intake and risk of psoriasis, psoriatic arthritis, and atopic dermatitis among United States women［J］. J Am Acad Dermatol, 2020,82（3）:661⁃665. doi: 10.1016/j.jaad.2019.08.007.
［10］	De Bastiani R, Gabrielli M, Lora L, et al. Association between coeliac disease and psoriasis: Italian primary care multicentre study［J］. Dermatology, 2015,230（2）:156⁃160. doi: 10.1159/000369615.
［11］	Michaëlsson G, Gerdén B, Hagforsen E, et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten⁃free diet［J］. Br J Dermatol, 2000,142（1）:44⁃51. doi: 10.1046/j.1365⁃2133.2000.03240.x.
［12］	Michaëlsson G, Ahs S, Hammarström I, et al. Gluten⁃free diet in psoriasis patients with antibodies to gliadin results in decreased expression of tissue transglutaminase and fewer Ki67+ cells in the dermis［J］. Acta Derm Venereol, 2003,83（6）:425⁃429. doi: 10.1080/00015550310015022.
［13］	Ford AR, Siegel M, Bagel J, et al. Dietary recommendations for adults with psoriasis or psoriatic arthritis from the Medical Board of the National Psoriasis Foundation: a systematic review［J］. JAMA Dermatol, 2018,154（8）:934⁃950. doi: 10.1001/jamadermatol.2018.1412.
［14］	Phan C, Touvier M, Kesse⁃Guyot E, et al. Association between Mediterranean anti⁃inflammatory dietary profile and severity of psoriasis: results from the NutriNet⁃Santé cohort［J］. JAMA Dermatol, 2018,154（9）:1017⁃1024. doi: 10.1001/jamadermatol. 2018.2127.
［15］	Molina⁃Leyva A, Cuenca⁃Barrales C, Vega⁃Castillo JJ, et al. Adherence to Mediterranean diet in Spanish patients with psoriasis: cardiovascular benefits?［J/OL］. Dermatol Ther, 2019,32（2）:e12810. doi: 10.1111/dth.12810.
［16］	Korovesi A, Dalamaga M, Kotopouli M, et al. Adherence to the Mediterranean diet is independently associated with psoriasis risk, severity, and quality of life: a cross⁃sectional observational study［J/OL］. Int J Dermatol, 2019,58（9）:e164⁃e165. doi: 10. 1111/ijd.14523.
［17］	Mahil SK, McSweeney SM, Kloczko E, et al. Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A critically appraised topic［J］. Br J Dermatol, 2019,181（5）:946⁃953. doi: 10.1111/bjd.17741.
［18］	Paroutoglou K, Papadavid E, Christodoulatos GS, et al. Deciphering the association between psoriasis and obesity: current evidence and treatment considerations［J］. Curr Obes Rep, 2020,9（3）:165⁃178. doi: 10.1007/s13679⁃020⁃00380⁃3.
［19］	Jensen P, Zachariae C, Christensen R, et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study［J］. JAMA Dermatol, 2013,149（7）:795⁃801. doi: 10.1001/jamadermatol. 2013.722.
［20］	Jensen P, Christensen R, Zachariae C, et al. Long⁃term effects of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observational follow⁃up study［J］. Am J Clin Nutr, 2016,104（2）:259⁃265. doi: 10.3945/ajcn.115.125849.
［21］	Castaldo G, Rastrelli L, Galdo G, et al. Aggressive weight⁃loss program with a ketogenic induction phase for the treatment of chronic plaque psoriasis: a proof⁃of⁃concept, single⁃arm, open⁃label clinical trial［J/OL］. Nutrition, 2020,74:110757. doi: 10.1016/j.nut.2020.110757.
［22］	Castaldo G, Pagano I, Grimaldi M, et al. Effect of very⁃low⁃calorie ketogenic diet on psoriasis patients: a nuclear magnetic resonance⁃based metabolomic study［J］. J Proteome Res, 2021,20（3）:1509⁃1521. doi: 10.1021/acs.jproteome.0c00646.
［23］	Klingberg E, Bilberg A, Björkman S, et al. Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study［J］. Arthritis Res Ther, 2019,21（1）:17. doi: 10.1186/s13075⁃019⁃1810⁃5.
［24］	Klingberg E, Björkman S, Eliasson B, et al. Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow⁃up［J］. Arthritis Res Ther, 2020,22（1）:254. doi: 10.1186/s13075⁃020⁃02350⁃5.
［25］	Horrobin DF. Low prevalences of coronary heart disease （CHD）, psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid （EPA）, a genetic variation of essential fatty acid （EFA） metabolism or a combination of both?［J］. Med Hypotheses, 1987,22（4）:421⁃428. doi: 10.1016/0306⁃9877（87）90037⁃5.
［26］	Tveit KS, Brokstad KA, Berge RK, et al. A randomized, double⁃blind, placebo⁃controlled clinical study to investigate the efficacy of herring roe oil for treatment of psoriasis［J］. Acta Derm Venereol, 2020,100（10）:adv00154. doi: 10.2340/00015 555⁃3507.
［27］	Søyland E, Funk J, Rajka G, et al. Effect of dietary supplementation with very⁃long⁃chain n⁃3 fatty acids in patients with psoriasis［J］. N Engl J Med, 1993,328（25）:1812⁃1816. doi: 10.1056/NEJM199306243282504.
［28］	Yang SJ, Chi CC. Effects of fish oil supplement on psoriasis: a meta⁃analysis of randomized controlled trials［J］. BMC Complement Altern Med, 2019,19（1）:354. doi: 10.1186/s12906⁃019⁃2777⁃0.
［29］	Lee YH, Song GG. Association between circulating 25⁃hydroxyvitamin D levels and psoriasis, and correlation with disease severity: a meta⁃analysis［J］. Clin Exp Dermatol, 2018,43（5）:529⁃535. doi: 10.1111/ced.13381.
［30］	Ingram MA, Jones MB, Stonehouse W, et al. Oral vitamin D3 supplementation for chronic plaque psoriasis: a randomized, double⁃blind, placebo⁃controlled trial［J］. J Dermatolog Treat, 2018,29（7）:648⁃657. doi: 10.1080/09546634.2018.1444728.
［31］	Finamor DC, Sinigaglia⁃Coimbra R, Neves LC, et al. A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis［J］. Dermatoendocrinol, 2013,5（1）:222⁃234. doi: 10. 4161/derm.24808.
［32］	Brazzelli V, Grasso V, Fornara L, et al. Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity［J］. Int J Immunopathol Pharmacol, 2010,23（3）:911⁃916. doi: 10.1177/039463201002300327.
［33］	Abedini R, Goodarzi A, Saeidi V, et al. Serum homocysteine level, vitamin B12 levels, and erythrocyte folate in psoriasis: a case⁃control study［J］. Int J Womens Dermatol, 2019,5（3）:171⁃174. doi: 10.1016/j.ijwd.2018.12.004.
［34］	Ruedemann R Jr. Treatment of psoriasis with large doses of vitamin B12, 1,100 micrograms per cubic centimeter; preliminary clinical report［J］. AMA Arch Derm Syphilol, 1954,69（6）:738⁃739. doi: 10.1001/archderm.1954.01540180088013.
［35］	Baker H, Comaish JS. Is vitamin B12 of value in psoriasis?［J］. Br Med J, 1962,2（5321）:1729⁃1730. doi: 10.1136/bmj.2.5321. 1729.
［36］	Lv J, Ai P, Lei S, et al. Selenium levels and skin diseases: systematic review and meta⁃analysis［J/OL］. J Trace Elem Med Biol, 2020,62:126548. doi: 10.1016/j.jtemb.2020.126548.
［37］	Gangadevi V, Thatikonda S, Pooladanda V, et al. Selenium nanoparticles produce a beneficial effect in psoriasis by reducing epidermal hyperproliferation and inflammation［J］. J Nanobiotechnology, 2021,19（1）:101. doi: 10.1186/s12951⁃021⁃00842⁃3.
［38］	Kharaeva Z, Gostova E, De Luca C, et al. Clinical and biochemical effects of coenzyme Q（10）, vitamin E, and selenium supplementation to psoriasis patients［J］. Nutrition, 2009,25（3）:295⁃302. doi: 10.1016/j.nut.2008.08.015.
［39］	Serwin AB, Wasowicz W, Chodynicka B. Selenium supplementation, soluble tumor necrosis factor⁃alpha receptor type 1, and C⁃reactive protein during psoriasis therapy with narrowband ultraviolet B［J］. Nutrition, 2006,22（9）:860⁃864. doi: 10.1016/j.nut.2006.05.011.
［40］	Winiarska⁃Mieczan A, Mieczan T, Wójcik G. Importance of redox equilibrium in the pathogenesis of psoriasis⁃impact of antioxidant⁃rich diet［J］. Nutrients, 2020,12（6）:1841. doi: 10.3390/nu12061841.
［41］	王丽玮, 罗玲玲, 崔盘根, 等. 肠道菌群与银屑病关系的研究进展［J］. 中华皮肤科杂志, 2019,52（5）:357⁃360. doi: 10.3760/cma.j.issn.0412⁃4030.2019.05.018.
［42］	Xiao S, Zhang G, Jiang C, et al. Deciphering gut microbiota dysbiosis and corresponding genetic and metabolic dysregulation in psoriasis patients using metagenomics sequencing［J/OL］. Front Cell Infect Microbiol, 2021,11:605825. doi: 10.3389/fcimb. 2021.605825.
［43］	Chen YH, Wu CS, Chao YH, et al. Lactobacillus pentosus GMNL⁃77 inhibits skin lesions in imiquimod⁃induced psoriasis⁃like mice［J］. J Food Drug Anal, 2017,25（3）:559⁃566. doi: 10.1016/j.jfda.2016.06.003.
［44］	Groeger D, O′Mahony L, Murphy EF, et al. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut［J］. Gut Microbes, 2013,4（4）:325⁃339. doi: 10.4161/gmic.25487.
［45］	Navarro⁃López V, Martínez⁃Andrés A, Ramírez⁃Boscá A, et al. Efficacy and safety of oral administration of a mixture of probiotic strains in patients with psoriasis: a randomized controlled clinical trial［J］. Acta Derm Venereol, 2019,99（12）:1078⁃1084. doi: 10.2340/00015555⁃3305.

[1]	闪莹常晓彤左亚刚. 自身免疫性疱病的表位扩展现象[J]. 中华皮肤科杂志, 2023, 56(7): 702-705.
[2]	唐志铭荆梦晴陆鹭单霄张翠侠张晓宇孟飒. 犀地凉血方通过LncRNA NEAT1/miR-485-5p/ STAT3调控网络对HaCaT细胞增殖、凋亡影响的研究[J]. 中华皮肤科杂志, 2023, 56(7): 642-650.
[3]	中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南（2023版）[J]. 中华皮肤科杂志, 2023, 56(7): 573-625.
[4]	蒋晓妍高敏张晓艳刘宁远. 白细胞介素17和白细胞介素23拮抗剂治疗脓疱型银屑病研究进展[J]. 中华皮肤科杂志, 2023, 56(7): 689-692.
[5]	中国医师协会皮肤科医师分会中华医学会皮肤性病学分会空军军医大学西京医院中国银屑病患者饮食指南制订工作组. 中国银屑病患者饮食管理指南（2023）[J]. 中华皮肤科杂志, 2023, 56(5): 389-401.
[6]	连盼盼刘军苏忠兰王宏伟. 过氧化物酶体增殖物激活受体γ对皮肤生理功能和病理过程的影响[J]. 中华皮肤科杂志, 2023, 56(4): 365-368.
[7]	刘小扬赵琰蔡林张建中. 银屑病患者白细胞介素17拮抗剂治疗后出现特应性皮炎样皮疹4例分析与文献回顾[J]. 中华皮肤科杂志, 2023, 0(3): 20210794-e20210794.
[8]	阮诗钒张鹏林婷婷罗仁炜鲍思怡薛晨瑶童泽群张亮亮龚婷纪超. 寻常型银屑病与血脂异常的相关性研究[J]. 中华皮肤科杂志, 2023, 0(3): 20220322-e20220322.
[9]	中华医学会皮肤性病学分会银屑病专业委员会. 银屑病生物制剂达标治疗专家共识[J]. 中华皮肤科杂志, 2023, 56(3): 191-203.
[10]	周健俞晨王刚. 司库奇尤单抗治疗13例难治性局限性脓疱型银屑病的临床疗效与安全性观察[J]. 中华皮肤科杂志, 2023, 56(3): 247-251.
[11]	胡琨杨晶王巧林陈军臣张谧朱武张斌窦冠珅 Wendong Chen, 匡叶红. [开放获取] 依奇珠单抗治疗银屑病短期疗效的单中心病例回顾性研究[J]. 中华皮肤科杂志, 2023, 56(3): 210-215.
[12]	何谐栗玉珍. 靶向JAK-STAT信号通路治疗银屑病的研究进展[J]. 中华皮肤科杂志, 2023, 56(3): 273-278.
[13]	杨琦郑捷. 生物制剂治疗对银屑病相关心血管疾病的影响[J]. 中华皮肤科杂志, 2023, 56(2): 165-169.
[14]	黄贺张学军. 白细胞介素23抑制剂古塞奇尤单抗在银屑病治疗中的应用[J]. 中华皮肤科杂志, 2023, 56(2): 181-184.
[15]	陈良宏孙艳王敬玉吴严. 本维莫德在皮肤病中的研究进展[J]. 中华皮肤科杂志, 2023, 0(2): 20210875-e20210875.

饮食干预治疗银屑病的相关进展

Dietary intervention for the treatment of psoriasis

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 45

相关文章 15

Metrics

本文评价

推荐阅读 10